雅虎香港 搜尋

搜尋結果

  1. 2024年5月31日 · Stephen Padilla, 14 Jun 2024. Patients with resectable nonsmall cell lung cancer (NSCLC) enjoy sustained survival from neoadjuvant nivolumab when added to chemotherapy compared with chemotherapy alone, as seen in the 4-year analysis from the phase III CheckMate...

  2. 2024年5月31日 · Stephen Padilla, 14 Jun 2024. Patients with resectable nonsmall cell lung cancer (NSCLC) enjoy sustained survival from neoadjuvant nivolumab when added to chemotherapy compared with chemotherapy alone, as seen in the 4-year analysis from the phase III CheckMate...

  3. 2024年6月7日 · MIMS Vietnam Tin Chuyên Khoa Thần kinh cung cấp tin tức và bài báo y khoa mới nhất về thần kinh, bao gồm các thông tin về nghiên cứu và thử nghiệm lâm sàng, báo cáo hội nghị về sa sút trí tuệ, chóng mặt, đau nửa đầu, bại não, động kinh, đa xơ cứng, bệnh Parkinson, v.v...

  4. 2024年6月15日 · MIMS Pharmacy Indonesia brings you the latest medical news and articles on drugs and medications with clinical trials, research, conferences and more on the latest drugs, medications, pharmacological research, contraindications etc.

  5. 2024年5月31日 · Stephen Padilla, 14 Jun 2024. Patients with resectable nonsmall cell lung cancer (NSCLC) enjoy sustained survival from neoadjuvant nivolumab when added to chemotherapy compared with chemotherapy alone, as seen in the 4-year analysis from the phase III CheckMate... Ophthalmology.

  6. 2024年5月31日 · Stephen Padilla, 14 Jun 2024. Patients with resectable nonsmall cell lung cancer (NSCLC) enjoy sustained survival from neoadjuvant nivolumab when added to chemotherapy compared with chemotherapy alone, as seen in the 4-year analysis from the phase III CheckMate...

  7. 2024年5月31日 · Patients with resectable nonsmall cell lung cancer (NSCLC) enjoy sustained survival from neoadjuvant nivolumab when added to chemotherapy compared with chemotherapy alone, as seen in the 4-year analysis from the phase III CheckMate...

  1. 其他人也搜尋了